EUVIMEDEUVIMED entdecken
Crossref

Inflammation and Late-Life Depressive Symptoms: Inflammation et symptômes dépressifs chez les personnes âgées

Malcolm Forbes, M. Lotfaliany, B. Mengist, A-M. Isvoranu, C. Yu, P. Lacaze, M. Kang, T. Nguyen, R. L. Woods, J. J. McNeil, J. T. Neumann, M. Mohebbi und 1 weitere

The Canadian Journal of Psychiatry · 21.11.2026

DOI: 10.1177/07067437261500819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Canadian Journal of Psychiatry, online erschienen am 21.11.2026. Verfasst von Malcolm Forbes und 12 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Low-level systemic inflammation has been associated with late-life depressive symptoms. Whether individuals with higher inflammation derive preventive benefit from low-dose aspirin therapy is unknown.

Methods

We performed a post-hoc analysis of the ASPirin in Reducing Events in the Elderly (ASPREE) randomized, double-blind, placebo-controlled trial. Baseline high-sensitivity C-reactive protein (hsCRP) was measured in plasma and depressive symptoms were assessed annually using the Center for Epidemiologic Studies Depression 10 Scale (CES-D-10), with elevated symptoms defined as CES-D-10 ≥ 8. Participants with elevated depressive symptoms at baseline were excluded. We fitted population-averaged logistic generalized estimating equation models adjusted for baseline sociodemographic and lifestyle covariates, including an hsCRP × treatment interaction to test effect modification by aspirin.

Results

Higher baseline hsCRP was associated with increased odds of elevated depressive symptoms during follow-up (OR 1.07 per SD increase in hsCRP, 95% CI 1.03–1.11). Low-dose aspirin allocation did not modify the hsCRP-depressive symptoms association (interaction OR 1.02, 95% CI 0.94–1.10). Findings were similar after additional adjustment for comorbidity and other covariates.

Conclusions

In community-dwelling older adults during the ASPREE randomized trial period, higher baseline hsCRP was modestly associated with elevated depressive symptoms. There was no evidence that low-dose aspirin was associated with reduced risk of depressive symptoms among participants with higher baseline inflammation.

Zitieren

APA

Forbes, M., Lotfaliany, M., Mengist, B., Isvoranu, A., Yu, C., Lacaze, P., Kang, M., Nguyen, T., Woods, R. L., McNeil, J. J., Neumann, J. T., Mohebbi, M., & Berk, M. (2026). Inflammation and Late-Life Depressive Symptoms: Inflammation et symptômes dépressifs chez les personnes âgées. The Canadian Journal of Psychiatry. https://doi.org/10.1177/07067437261500819

Vancouver

Forbes M, Lotfaliany M, Mengist B, Isvoranu A, Yu C, Lacaze P, et al. Inflammation and Late-Life Depressive Symptoms: Inflammation et symptômes dépressifs chez les personnes âgées. The Canadian Journal of Psychiatry. 2026. doi:10.1177/07067437261500819

BibTeX
@article{Forbes2026,
  author = {Forbes, Malcolm and Lotfaliany, M. and Mengist, B. and Isvoranu, A-M. and Yu, C. and Lacaze, P. and Kang, M. and Nguyen, T. and Woods, R. L. and McNeil, J. J. and Neumann, J. T. and Mohebbi, M. and Berk, M.},
  title = {Inflammation and Late-Life Depressive Symptoms: Inflammation et symptômes dépressifs chez les personnes âgées},
  journal = {The Canadian Journal of Psychiatry},
  year = {2026},
  doi = {10.1177/07067437261500819}
}
Kostenlos starten →